MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia
Montesinos, Pau, Beckermann, Benjamin M, Catalani, Olivier, Esteve, Jordi, Gamel, Katia, Konopleva, Marina Y, Martinelli, Giovanni, Monnet, Annabelle, Papayannidis, Cristina, Park, Aaron, Récher, Christian, Rodríguez-Veiga, Rebeca, Röllig, Christoph, Vey, Norbert, Wei, Andrew H, Yoon, Sung-Soo, Fenaux, Pierre
Published in Future oncology (London, England) (01.05.2020)
Published in Future oncology (London, England) (01.05.2020)
Get full text
Journal Article
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study
Négrier, Claude, Mahlangu, Johnny, Lehle, Michaela, Chowdary, Pratima, Catalani, Olivier, Bernardi, Ronald J, Jiménez-Yuste, Víctor, Beckermann, Benjamin M, Schmitt, Christophe, Ventriglia, Giuliana, Windyga, Jerzy, d'Oiron, Roseline, Moorehead, Paul, Koparkar, Sunita, Teodoro, Vanda, Shapiro, Amy D, Oldenburg, Johannes, Hermans, Cedric
Published in The Lancet. Haematology (01.03.2023)
Published in The Lancet. Haematology (01.03.2023)
Get more information
Journal Article
Idasanutlin Plus Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia: Results of the MIRROS Trial
Konopleva, Marina Y., Röllig, Christoph, Cavenagh, Jamie, Deeren, Dries, Girshova, Larisa, Krauter, Jürgen, Martinelli, Giovanni, Montesinos, Pau, Schäfer, Jonas A., Ottmann, Oliver, Petrini, Mario, Pigneux, Arnaud, Rambaldi, Alessandro, Recher, Christian, Rodriguez-Veiga, Rebeca, Taussig, David, Vey, Norbert, Yoon, Sung-Soo, Ott, Marion, Muehlbauer, Susanne, Beckermann, Benjamin M., Catalani, Olivier, Genevray, Magali, Mundt, Kirsten, Jamois, Candice, Fenaux, Pierre, Wei, Andrew H.
Published in Blood advances (26.07.2022)
Published in Blood advances (26.07.2022)
Get full text
Journal Article
Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis
Hermans, Cedric, Ventriglia, Giuliana, Obaji, Samya, Beckermann, Benjamin M., Lehle, Michaela, Catalani, Olivier, d’Oiron, Roseline, Frenzel, Laurent
Published in Research and practice in thrombosis and haemostasis (01.11.2023)
Published in Research and practice in thrombosis and haemostasis (01.11.2023)
Get full text
Journal Article
Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma
Salnikov, Alexei V., Groth, Ariane, Apel, Anja, Kallifatidis, Georgios, Beckermann, Benjamin M., Khamidjanov, Akmal, Ryschich, Eduard, Büchler, Markus W., Herr, Ingrid, Moldenhauer, Gerhard
Published in Journal of cellular and molecular medicine (01.09.2009)
Published in Journal of cellular and molecular medicine (01.09.2009)
Get full text
Journal Article
Contribution of Idasanutlin Exposure to Safety, Pharmacodynamics and Clinical Response of Patients with Acute Myeloid Leukemia Treated with Idasanutlin + Cytarabine in Phase I and III Studies
Jamois, Candice, Anders, Doreen, Beckermann, Benjamin M., Genevray, Magali, Mundt, Kirsten, Petry, Claire, Yang, Joy, Kassir, Nastya, Schmitt, Christophe
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study
Négrier, Claude, Mahlangu, Johnny, Lehle, Michaela, Chowdary, Pratima, Catalani, Olivier, Jiménez-Yuste, Víctor, Beckermann, Benjamin M., Schmitt, Christophe, Hermans, Cedric, Ventriglia, Giuliana, Windyga, Jerzy, Kiialainen, Anna, d'Oiron, Roseline, Moorehead, Paul, Teodoro, Vanda, Shapiro, Amy D., Oldenburg, Johannes
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article